Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

Here's the next stock we think soars >>>

CBAY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,990,153.24

CymaBay Therapeutics Insider Trading History Chart

CymaBay Therapeutics Share Price & Price History

^$14.91

▼ -0.66 (-4.24%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

CymaBay Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/29/2023	Kurt Von Emster	Director	Sell	15,921	$15.68	$249,641.28	90,000
9/18/2023	Charles Mcwherter	Insider	Sell	21,746	$16.22	$352,720.12	15,000
9/15/2023	Paul T. Quinlan	General Counsel	Sell	53,000	$16.87	$894,110.00
8/18/2023	Charles Mcwherter	Insider	Sell	21,746	$11.47	$249,426.62	15,000
8/15/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$11.91	$59,550.00
8/9/2023	Daniel Menold	VP	Sell	20,945	$12.35	$258,670.75
7/18/2023	Charles Mcwherter	Insider	Sell	21,749	$11.43	$248,591.07	15,000
7/14/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$11.81	$59,050.00
6/30/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$10.05	$50,250.00
6/20/2023	Charles Mcwherter	Insider	Sell	21,749	$8.16	$177,471.84	15,000
5/18/2023	Charles Mcwherter	Insider	Sell	21,749	$9.08	$197,480.92	15,000
5/15/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$10.37	$51,850.00
4/17/2023	Dennis D. Kim	Insider	Sell	112,219	$9.54	$1,070,569.26	20,000
4/13/2023	Dennis D. Kim	Insider	Sell	7,781	$8.98	$69,873.38	20,000
3/28/2023	Dennis D. Kim	Insider	Sell	100	$8.98	$898.00	20,000
6/6/2022	Sujal Shah	CEO	Buy	51,301	$1.95	$100,036.95	171,301
1/19/2022	Dennis D. Kim	Insider	Buy	20,000	$3.04	$60,800.00

Easy Options Trading: A Complete Guide For Beginners

From Tradewins | Ad

Having no investing experience shouldn’t bar you from creating a stream of passive income through trading - you’ll just need to approach it differently!

Options expert Chuck Hughes’ coveted trading guide, “Options Trading Made Easy”, is tailor made for the inexperienced trader and can help you target a new stream of income faster than traditional trading.

Click here to download your free copy now!

SEC Filings (Institutional Ownership Changes) for CymaBay Therapeutics (NASDAQ:CBAY)

95.03% of CymaBay Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CymaBay Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/24/2023	Perceptive Advisors LLC	3,733,255	$40.88M	1.2%	-4.4%	3.804%
8/21/2023	Affinity Asset Advisors LLC	1,050,118	$11.50M	4.0%	-3.0%	1.070%
8/21/2023	California State Teachers Retirement System	96,825	$1.06M	0.0%	+30.2%	0.099%
8/16/2023	Nuveen Asset Management LLC	298,875	$3.27M	0.0%	N/A	0.305%
8/15/2023	Alliancebernstein L.P.	101,000	$1.11M	0.0%	N/A	0.103%
8/15/2023	Wells Fargo & Company MN	40,881	$0.45M	0.0%	+6,504.4%	0.042%
8/15/2023	Blueshift Asset Management LLC	19,413	$0.21M	0.1%	N/A	0.020%
8/15/2023	Walleye Capital LLC	234,643	$2.57M	0.0%	N/A	0.239%
8/15/2023	Goldman Sachs Group Inc.	573,145	$6.28M	0.0%	-25.9%	0.584%
8/15/2023	Royal Bank of Canada	6,088	$67K	0.0%	+23,315.4%	0.006%
8/15/2023	Silverarc Capital Management LLC	160,000	$1.75M	0.5%	N/A	0.163%
8/15/2023	HighVista Strategies LLC	338,842	$3.71M	1.7%	-2.6%	0.345%
8/15/2023	Bayesian Capital Management LP	38,900	$0.43M	0.0%	N/A	0.040%
8/14/2023	Cormorant Asset Management LP	3,800,000	$41.61M	2.3%	+198.9%	3.872%
8/14/2023	Tower Research Capital LLC TRC	25,879	$0.28M	0.0%	+1,315.7%	0.026%
8/14/2023	Two Sigma Securities LLC	16,517	$0.18M	0.0%	N/A	0.017%
8/14/2023	Schonfeld Strategic Advisors LLC	70,682	$0.77M	0.0%	N/A	0.072%
8/14/2023	Marshall Wace LLP	781,735	$8.56M	0.0%	+221.5%	0.796%
8/14/2023	State of Wisconsin Investment Board	81,315	$0.89M	0.0%	+4.1%	0.083%
8/14/2023	State Street Corp	2,308,493	$25.28M	0.0%	+245.0%	2.352%
8/14/2023	UniSuper Management Pty Ltd	400,887	$4.39M	0.0%	N/A	0.408%
8/14/2023	Nuveen Asset Management LLC	298,875	$3.27M	0.0%	N/A	0.305%
8/14/2023	Graham Capital Management L.P.	68,579	$0.75M	0.0%	-52.7%	0.070%
8/11/2023	Boulder Hill Capital Management LP	17,700	$0.19M	0.4%	N/A	0.018%
8/11/2023	Renaissance Technologies LLC	270,020	$2.96M	0.0%	-43.9%	0.277%
8/11/2023	Credit Suisse AG	172,057	$1.88M	0.0%	+161.7%	0.176%
8/11/2023	BlackRock Inc.	7,504,670	$82.18M	0.0%	+183.2%	7.696%
8/11/2023	Ameritas Investment Partners Inc.	8,100	$89K	0.0%	N/A	0.008%
8/11/2023	Campbell & CO Investment Adviser LLC	116,439	$1.28M	0.2%	+46.5%	0.119%
8/11/2023	State Board of Administration of Florida Retirement System	27,850	$0.31M	0.0%	N/A	0.029%
8/11/2023	The Manufacturers Life Insurance Company	37,630	$0.41M	0.0%	N/A	0.039%
8/11/2023	Franklin Resources Inc.	3,272,008	$35.83M	0.0%	+1.5%	3.356%
8/11/2023	Trexquant Investment LP	56,477	$0.62M	0.0%	-11.6%	0.058%
8/11/2023	Geode Capital Management LLC	1,855,470	$20.32M	0.0%	+105.0%	1.903%
8/11/2023	Sei Investments Co.	55,875	$0.61M	0.0%	N/A	0.057%
8/11/2023	JPMorgan Chase & Co.	423,461	$4.64M	0.0%	-21.9%	0.434%
8/11/2023	Northern Trust Corp	975,399	$10.68M	0.0%	+365.6%	1.000%
8/10/2023	MetLife Investment Management LLC	51,802	$0.57M	0.0%	N/A	0.053%
8/10/2023	Metropolitan Life Insurance Co NY	5,368	$59K	0.0%	N/A	0.006%
8/10/2023	Great West Life Assurance Co. Can	2,946	$32K	0.0%	-36.0%	0.003%
8/10/2023	ProShare Advisors LLC	19,066	$0.21M	0.0%	N/A	0.020%
8/10/2023	Profund Advisors LLC	19,751	$0.22M	0.0%	+49.6%	0.020%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	48,043	$0.53M	0.0%	N/A	0.049%
8/10/2023	Nicholas Investment Partners LP	696,947	$7.63M	0.5%	N/A	0.715%
8/10/2023	Charles Schwab Investment Management Inc.	264,734	$2.90M	0.0%	+588.0%	0.271%
8/10/2023	Citigroup Inc.	48,597	$0.53M	0.0%	-79.3%	0.050%
8/9/2023	Dimensional Fund Advisors LP	1,167,413	$12.77M	0.0%	-1.3%	1.197%
8/9/2023	BNP Paribas Arbitrage SNC	25,579	$0.28M	0.0%	-85.2%	0.026%
8/9/2023	Swiss National Bank	158,900	$1.74M	0.0%	-13.0%	0.163%
8/8/2023	Rhumbline Advisers	126,026	$1.38M	0.0%	N/A	0.129%
8/8/2023	AlphaCentric Advisors LLC	15,000	$0.16M	0.1%	N/A	0.015%
8/7/2023	Principal Financial Group Inc.	11,579	$0.13M	0.0%	N/A	0.012%
8/4/2023	American International Group Inc.	47,213	$0.52M	0.0%	N/A	0.048%
8/3/2023	Barclays PLC	54,241	$0.59M	0.0%	+101.1%	0.049%
8/3/2023	Jennison Associates LLC	1,671,532	$18.30M	0.0%	+168.0%	1.714%
8/3/2023	Mackenzie Financial Corp	35,660	$0.42M	0.0%	-28.9%	0.037%
8/3/2023	Bank of New York Mellon Corp	377,487	$4.13M	0.0%	+844.2%	0.387%
8/1/2023	Arizona State Retirement System	20,496	$0.22M	0.0%	-16.5%	0.021%
7/31/2023	LPL Financial LLC	131,570	$1.44M	0.0%	+10.7%	0.135%
7/31/2023	Strs Ohio	12,300	$0.13M	0.0%	N/A	0.013%
7/28/2023	Moody Aldrich Partners LLC	115,340	$1.26M	0.2%	N/A	0.118%
7/27/2023	Victory Capital Management Inc.	48,750	$0.53M	0.0%	+383.8%	0.050%
7/25/2023	Raymond James Financial Services Advisors Inc.	97,895	$1.07M	0.0%	+62.7%	0.100%
7/25/2023	Raymond James & Associates	34,465	$0.38M	0.0%	+55.5%	0.035%
7/19/2023	Teacher Retirement System of Texas	19,833	$0.22M	0.0%	-24.0%	0.020%
7/11/2023	Harbor Capital Advisors Inc.	4,701	$51K	0.0%	N/A	0.005%
6/1/2023	Prelude Capital Management LLC	10,973	$96K	0.0%	N/A	0.011%
6/1/2023	Golden State Equity Partners	50,000	$0.44M	0.2%	N/A	0.051%
5/18/2023	JPMorgan Chase & Co.	542,407	$4.73M	0.0%	+18,028.6%	0.556%
5/16/2023	Hudson Bay Capital Management LP	266,400	$2.32M	0.0%	-61.8%	0.274%
5/16/2023	Perceptive Advisors LLC	3,903,255	$34.04M	1.0%	+450.5%	4.010%
5/16/2023	State Street Corp	669,036	$5.83M	0.0%	+97.8%	0.687%
5/16/2023	Saturn V Capital Management LLC	1,629,464	$14.21M	10.6%	+1.1%	1.674%
5/16/2023	Squarepoint Ops LLC	93,882	$0.82M	0.0%	+836.3%	0.096%
5/16/2023	Geode Capital Management LLC	904,958	$7.89M	0.0%	+14.6%	0.930%
5/16/2023	Great Point Partners LLC	507,500	$4.43M	0.9%	-67.3%	0.521%
5/16/2023	Graham Capital Management L.P.	144,974	$1.26M	0.0%	+435.4%	0.149%
5/16/2023	Altium Capital Management LP	620,000	$5.41M	3.0%	-39.5%	0.637%
5/16/2023	Balyasny Asset Management L.P.	1,957,068	$17.07M	0.0%	+3,439.1%	2.011%
5/16/2023	Bain Capital Life Sciences Investors LLC	2,500,000	$21.80M	2.7%	N/A	2.569%
5/15/2023	Cubist Systematic Strategies LLC	531,381	$4.63M	0.0%	+896.4%	0.546%
5/15/2023	Artia Global Partners LP	169,277	$1.48M	0.5%	N/A	0.174%
5/15/2023	Affinity Asset Advisors LLC	1,083,118	$9.45M	3.1%	-5.3%	1.113%
5/15/2023	Commodore Capital LP	2,025,000	$17.66M	2.7%	-64.7%	2.081%
5/15/2023	Logos Global Management LP	400,000	$3.49M	0.5%	-68.0%	0.411%
5/15/2023	Two Sigma Advisers LP	1,414,838	$12.34M	0.0%	+250.6%	1.454%
5/15/2023	Two Sigma Investments LP	1,419,540	$12.38M	0.0%	+264.8%	1.458%
5/15/2023	Deutsche Bank AG	395,089	$3.45M	0.0%	+210.6%	0.406%
5/15/2023	Price T Rowe Associates Inc. MD	72,611	$0.63M	0.0%	-43.9%	0.075%
5/15/2023	Boothbay Fund Management LLC	16,249	$0.14M	0.0%	-10.1%	0.017%
5/15/2023	Healthcare of Ontario Pension Plan Trust Fund	386,600	$3.37M	0.0%	N/A	0.397%
5/12/2023	Renaissance Technologies LLC	481,500	$4.20M	0.0%	-4.8%	0.495%
5/12/2023	Great West Life Assurance Co. Can	4,602	$40K	0.0%	N/A	0.005%
5/12/2023	BlackRock Inc.	2,650,077	$23.11M	0.0%	+31.5%	2.723%
5/12/2023	BNP Paribas Arbitrage SNC	172,714	$1.51M	0.0%	+33,050.5%	0.177%
5/12/2023	Bank of America Corp DE	525,693	$4.58M	0.0%	+387.5%	0.540%
5/12/2023	Franklin Resources Inc.	3,224,862	$28.12M	0.0%	+13,862.3%	3.313%
5/12/2023	Mirabella Financial Services LLP	58,180	$0.51M	0.1%	+133.9%	0.060%
5/12/2023	HRT Financial LP	385,676	$3.36M	0.0%	+419.8%	0.396%
5/12/2023	Dimensional Fund Advisors LP	1,183,236	$10.32M	0.0%	-10.0%	1.216%

Data available starting January 2016

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of autoimmune liver disease, primary biliary cholangitis (PBC). The company also develops MBX-2982 for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.

Today's Range

Now: $14.91

$14.88

$15.91

50 Day Range

MA: $13.80

$11.55

$17.62

52 Week Range

Now: $14.91

$3.15

$18.20

Volume

2,857,048 shs

Average Volume

3,115,392 shs

Market Capitalization

$1.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of CymaBay Therapeutics?: CymaBay Therapeutics' top insider shareholders include:
Sujal Shah (CEO)
Kurt Von Emster (Director)
Dennis D Kim (Insider)
Charles Mcwherter (Insider)
Daniel Menold (VP)
Paul T Quinlan (General Counsel)
Learn More about top insider investors at CymaBay Therapeutics.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

CBAY Insider Trading

CymaBay Therapeutics Insider Trading History Chart

CymaBay Therapeutics Share Price & Price History

CymaBay Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for CymaBay Therapeutics (NASDAQ:CBAY)

Institutional Buying and Selling by Quarter

CymaBay Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of CymaBay Therapeutics?